Description: medmix AG designs, produces, and sells high-precision devices and services for the healthcare, consumer, and industrial end markets worldwide. The company operates through Dental, Drug Delivery, Surgery, Industry, and Beauty segments. The company offers dental products, including mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, adhesives, restoratives, prevention, esthetics and endodontics; drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases; and mixing and delivery devices which are used to inject bone tissue, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. It also produces and markets dispensers, mixing tips, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics assembly, infrastructure, and DIY industries; and micro-brushes used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments, such as anti-aging treatments. It offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Baar, Switzerland.
Home Page: www.medmix.swiss
Neuhofstrasse 20
Baar,
6340
Switzerland
Phone:
41 41 723 7375
Officers
Name | Title |
---|---|
Ms. Jennifer Dean | Chief Financial Officer |
Ms. Sheel Gill | Head of M&A, Strategy & Investor Relations |
Mr. Schops Xavier | Chief Legal Officer, Company Secretary & Head of Corporate Affairs |
Ms. Itee Satpathy | Chief Human Resources & Sustainability Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 1740 |
Price-to-Book MRQ: | 1.3652 |
Price-to-Sales TTM: | 1.4795 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 2695 |